Why is Fischer Medical Ventures Ltd ?
1
Poor Management Efficiency with a low ROE of 1.39%
- The company has been able to generate a Return on Equity (avg) of 1.39% signifying low profitability per unit of shareholders funds
2
With ROE of 0.4, it has a Very Expensive valuation with a 6.5 Price to Book Value
- Over the past year, while the stock has generated a return of 0.00%, its profits have fallen by -20%
3
Falling Participation by Institutional Investors
- Institutional investors have decreased their stake by -0.81% over the previous quarter and collectively hold 6.22% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Commodity Chemicals)
When to re-enter? - We will constantly monitor the company and review our call based on new data
No Data Found
Quality key factors
Factor
Value
Sales Growth (5y)
427.60%
EBIT Growth (5y)
0.60%
EBIT to Interest (avg)
1.69
Debt to EBITDA (avg)
9.13
Net Debt to Equity (avg)
-0.04
Sales to Capital Employed (avg)
0.27
Tax Ratio
37.27%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
6.22%
ROCE (avg)
1.92%
ROE (avg)
1.39%
Valuation Key Factors 
Factor
Value
P/E Ratio
1591
Industry P/E
39
Price to Book Value
6.50
EV to EBIT
1376.68
EV to EBITDA
700.78
EV to Capital Employed
6.70
EV to Sales
21.02
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
0.49%
ROE (Latest)
0.41%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Bullish
Technical Movement
37What is working for the Company
NET SALES(Latest six months)
At Rs 109.75 cr has Grown at 120.47%
PAT(Latest six months)
At Rs 19.00 cr has Grown at 5,487.15%
PBT LESS OI(Q)
At Rs 14.82 cr has Grown at 1226.2% (vs previous 4Q average
OPERATING PROFIT TO NET SALES(Q)
Highest at 18.84%
PBDIT(Q)
Highest at Rs 16.26 cr.
EPS(Q)
Highest at Rs 2.14
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Fischer Medical
Net Sales - Quarterly
At Rs 86.31 cr has Grown at 178.4% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 31.01 CrMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 14.82 cr has Grown at 1226.2% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 1.12 CrMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 13.93 cr has Grown at 743.2% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 1.65 CrMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 18.84% and Grown
each quarter in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Net Sales - Quarterly
Highest at Rs 86.31 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 16.26 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 14.82 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 13.93 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 2.14
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)






